Andrew Satlin

Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease

N. Bodick, Walter Offen, Allan I. Levey et al. · Archives of Neurology · 1997 · 685 citations

Medicine, Neurology, Pharmacology +17

Preclinical prediction of Alzheimer's disease using SPECT

Keith A. Johnson, Kelvyn Jones, B.L. Holman et al. · Neurology · 1998 · 471 citations

Medicine, Neurology, Neuroscience +17

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

Suzanne Oparil, Steven A. Yarows, Samir Patel et al. · The Lancet · 2007 · 442 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Sundowning and Circadian Rhythms in Alzheimer’s Disease

L. Volicer, David G. Harper, Barbara C. Manning et al. · American Journal of Psychiatry · 2001 · 382 citations

Nursing, Geriatric Medicine, Physiology +17

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study

Patricia Murphy, Margaret Moline, David Mayleben et al. · Journal of Clinical Sleep Medicine · 2017 · 323 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17